Annual Accounts Receivable
$1.28 M
+$1.14 M+772.79%
31 December 2023
Summary:
Cytokinetics Incorporated annual accounts receivable is currently $1.28 million, with the most recent change of +$1.14 million (+772.79%) on 31 December 2023. During the last 3 years, it has fallen by -$3.14 million (-70.97%). CYTK annual accounts receivable is now -97.52% below its all-time high of $51.82 million, reached on 31 December 2021.CYTK Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$244.00 K
+$244.00 K+100.00%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly accounts receivable is currently $244.00 thousand, with the most recent change of +$244.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-90.24%). CYTK quarterly accounts receivable is now -99.64% below its all-time high of $67.00 million, reached on 30 September 2016.CYTK Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +772.8% | -90.2% |
| 3 y3 years | -71.0% | -62.1% |
| 5 y5 years | -42.5% | -96.3% |
CYTK Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -97.5% | +772.8% | -99.5% | |
| 5 y | 5 years | -97.5% | +772.8% | -99.5% | |
| alltime | all time | -97.5% | >+9999.0% | -99.6% |
Cytokinetics Incorporated Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $244.00 K(>+9900.0%) |
| June 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $834.00 K(-35.0%) |
| Dec 2023 | $1.28 M(+772.8%) | $1.28 M(-48.7%) |
| Sept 2023 | - | $2.50 M(+153.7%) |
| June 2023 | - | $985.00 K(-2.1%) |
| Mar 2023 | - | $1.01 M(+584.4%) |
| Dec 2022 | $147.00 K(-99.7%) | $147.00 K(-93.6%) |
| Sept 2022 | - | $2.29 M(+16.3%) |
| June 2022 | - | $1.97 M(-67.4%) |
| Mar 2022 | - | $6.06 M(-88.3%) |
| Dec 2021 | $51.82 M(+1072.4%) | $51.82 M(+7946.4%) |
| Sept 2021 | - | $644.00 K(-76.2%) |
| June 2021 | - | $2.70 M(-40.2%) |
| Mar 2021 | - | $4.51 M(+2.1%) |
| Dec 2020 | $4.42 M(-14.4%) | $4.42 M(-11.0%) |
| Sept 2020 | - | $4.96 M(+120.3%) |
| June 2020 | - | $2.25 M(-16.6%) |
| Mar 2020 | - | $2.70 M(-47.6%) |
| Dec 2019 | $5.16 M(+131.4%) | $5.16 M(-21.5%) |
| Sept 2019 | - | $6.58 M(-26.9%) |
| June 2019 | - | $8.99 M(+115.9%) |
| Mar 2019 | - | $4.17 M(+86.7%) |
| Dec 2018 | $2.23 M(+100.6%) | $2.23 M(-75.6%) |
| Sept 2018 | - | $9.16 M(+3779.7%) |
| June 2018 | - | $236.00 K(+537.8%) |
| Mar 2018 | - | $37.00 K(-96.7%) |
| Dec 2017 | $1.11 M(+4533.3%) | $1.11 M(-88.9%) |
| Sept 2017 | - | $10.00 M(>+9900.0%) |
| June 2017 | - | $0.00(-100.0%) |
| Mar 2017 | - | $910.00 K(+3691.7%) |
| Dec 2016 | $24.00 K(+100.0%) | $24.00 K(-100.0%) |
| Sept 2016 | - | $67.00 M(>+9900.0%) |
| June 2016 | - | $26.00 K(>+9900.0%) |
| Mar 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $12.00 K(-100.0%) | $12.00 K(-74.5%) |
| Sept 2015 | - | $47.00 K(+1075.0%) |
| June 2015 | - | $4000.00(-99.6%) |
| Mar 2015 | - | $970.00 K(-97.9%) |
| Dec 2014 | $46.65 M | $46.65 M(+3816.5%) |
| Sept 2014 | - | $1.19 M(+273.4%) |
| June 2014 | - | $319.00 K(-84.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $2.12 M(>+9900.0%) |
| Dec 2013 | $5000.00(+25.0%) | $5000.00(>+9900.0%) |
| Sept 2013 | - | $0.00(-100.0%) |
| June 2013 | - | $16.00 M(+4778.0%) |
| Mar 2013 | - | $328.00 K(+8100.0%) |
| Dec 2012 | $4000.00(-71.4%) | $4000.00(>+9900.0%) |
| Sept 2012 | - | $0.00(-100.0%) |
| June 2012 | - | $3000.00(-96.4%) |
| Mar 2012 | - | $83.00 K(+492.9%) |
| Dec 2011 | $14.00 K(-69.6%) | $14.00 K(-87.9%) |
| Sept 2011 | - | $116.00 K(+329.6%) |
| June 2011 | - | $27.00 K(-20.6%) |
| Mar 2011 | - | $34.00 K(-26.1%) |
| Dec 2010 | $46.00 K(-74.4%) | $46.00 K(-82.4%) |
| Sept 2010 | - | $262.00 K(+24.2%) |
| June 2010 | - | $211.00 K(+1818.2%) |
| Mar 2010 | - | $11.00 K(-93.9%) |
| Dec 2009 | $180.00 K(-18.6%) | $180.00 K(-96.0%) |
| Sept 2009 | - | $4.54 M(+770.5%) |
| June 2009 | - | $522.00 K(+7357.1%) |
| Mar 2009 | - | $7000.00(-96.8%) |
| Dec 2008 | $221.00 K(+154.0%) | $221.00 K(+220.3%) |
| Sept 2008 | - | $69.00 K(+15.0%) |
| June 2008 | - | $60.00 K(+3.4%) |
| Mar 2008 | - | $58.00 K(-33.3%) |
| Dec 2007 | $87.00 K(-99.8%) | $87.00 K(-33.1%) |
| Sept 2007 | - | $130.00 K(+100.0%) |
| June 2007 | - | $65.00 K(-51.1%) |
| Mar 2007 | - | $133.00 K(-99.7%) |
| Dec 2006 | $42.07 M(+7204.0%) | $42.07 M(>+9900.0%) |
| Sept 2006 | - | $63.00 K(-11.3%) |
| June 2006 | - | $71.00 K(+42.0%) |
| Mar 2006 | - | $50.00 K(-91.3%) |
| Dec 2005 | $576.00 K(+986.8%) | $576.00 K(-41.5%) |
| Sept 2005 | - | $984.00 K(+366.4%) |
| June 2005 | - | $211.00 K(+61.1%) |
| Mar 2005 | - | $131.00 K(+147.2%) |
| Dec 2004 | $53.00 K(-79.8%) | $53.00 K(-70.9%) |
| Sept 2004 | - | $182.00 K(-8.1%) |
| June 2004 | - | $198.00 K(-2.9%) |
| Mar 2004 | - | $204.00 K(-22.4%) |
| Dec 2003 | $263.00 K(+1543.8%) | $263.00 K |
| Dec 2002 | $16.00 K | - |
FAQ
- What is Cytokinetics Incorporated annual accounts receivable?
- What is the all time high annual accounts receivable for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual accounts receivable year-on-year change?
- What is Cytokinetics Incorporated quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly accounts receivable year-on-year change?
What is Cytokinetics Incorporated annual accounts receivable?
The current annual accounts receivable of CYTK is $1.28 M
What is the all time high annual accounts receivable for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual accounts receivable is $51.82 M
What is Cytokinetics Incorporated annual accounts receivable year-on-year change?
Over the past year, CYTK annual accounts receivable has changed by +$1.14 M (+772.79%)
What is Cytokinetics Incorporated quarterly accounts receivable?
The current quarterly accounts receivable of CYTK is $244.00 K
What is the all time high quarterly accounts receivable for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly accounts receivable is $67.00 M
What is Cytokinetics Incorporated quarterly accounts receivable year-on-year change?
Over the past year, CYTK quarterly accounts receivable has changed by -$2.25 M (-90.24%)